Healthcare provider profile · identity verified

Samuel Taylor Plost, M.D.

Internal Medicine · NEW ORLEANS, LA · NPI 1083956031

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	593	173
Amlodipine Besylate	Amlodipine Besylate	429	131
Rosuvastatin Calcium	Rosuvastatin Calcium	395	129
Levothyroxine Sodium	Levothyroxine Sodium	247	70
Gabapentin	Gabapentin	160	40
Tamsulosin Hcl	Tamsulosin Hcl	158	42
Pantoprazole Sodium	Pantoprazole Sodium	150	43
Losartan Potassium	Losartan Potassium	146	49
Escitalopram Oxalate	Escitalopram Oxalate	145	45
Carvedilol	Carvedilol	144	38
Ozempic	Semaglutide	140	33
Metoprolol Succinate	Metoprolol Succinate	139	42
Omeprazole	Omeprazole	139	42
Trazodone Hcl	Trazodone Hcl	127	32
Lisinopril	Lisinopril	125	35
Pravastatin Sodium	Pravastatin Sodium	114	28
Olmesartan Medoxomil	Olmesartan Medoxomil	111	32
Allopurinol	Allopurinol	110	36
Metformin Hcl	Metformin Hcl	109	36
Metformin Hcl Er	Metformin Hcl	108	38
Albuterol Sulfate Hfa	Albuterol Sulfate	106	39
Eliquis	Apixaban	106	26
Hydrochlorothiazide	Hydrochlorothiazide	102	33
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	100	27
Bupropion Xl	Bupropion Hcl	94	23
Valsartan	Valsartan	90	29
Spironolactone	Spironolactone	88	25
Zolpidem Tartrate	Zolpidem Tartrate	82	12
Mounjaro	Tirzepatide	81	16
Amitriptyline Hcl	Amitriptyline Hcl	80	28
Azelastine Hcl	Azelastine Hcl	78	47
Meloxicam	Meloxicam	78	29
Duloxetine Hcl	Duloxetine Hcl	76	22
Alprazolam	Alprazolam	75	16
Citalopram Hbr	Citalopram Hydrobromide	73	21
Jardiance	Empagliflozin	69	16
Simvastatin	Simvastatin	68	18
Furosemide	Furosemide	65	24
Nifedipine Er	Nifedipine	64	21
Chlorthalidone	Chlorthalidone	63	20
Januvia	Sitagliptin Phosphate	60	21
Famotidine	Famotidine	59	20
Venlafaxine Hcl Er	Venlafaxine Hcl	58	14
Sertraline Hcl	Sertraline Hcl	57	16
Fluticasone Propionate	Fluticasone Propionate	55	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	17
Clopidogrel	Clopidogrel Bisulfate	52	19
Lorazepam	Lorazepam	50	suppressed
Potassium Chloride	Potassium Chloride	50	20
Pregabalin	Pregabalin	44	11
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	42	11
Tramadol Hcl	Tramadol Hcl	42	suppressed
Buspirone Hcl	Buspirone Hcl	40	suppressed
Finasteride	Finasteride	40	13
Esomeprazole Magnesium	Esomeprazole Magnesium	37	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	16
Baclofen	Baclofen	36	suppressed
Topiramate	Topiramate	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	suppressed
Diazepam	Diazepam	35	12
Irbesartan	Irbesartan	35	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	12
Metoprolol Tartrate	Metoprolol Tartrate	35	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Ezetimibe	Ezetimibe	32	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Xarelto	Rivaroxaban	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	16
Clonazepam	Clonazepam	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Acyclovir	Acyclovir	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	11
Spiriva Respimat	Tiotropium Bromide	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Atenolol	Atenolol	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	26	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	11
Myrbetriq	Mirabegron	25	suppressed
Terbinafine Hcl	Terbinafine Hcl	25	17
Naproxen	Naproxen	24	11
Ondansetron Odt	Ondansetron	24	14
Prednisone	Prednisone	24	16
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Mirtazapine	Mirtazapine	22	11
Trulicity	Dulaglutide	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Belsomra	Suvorexant	20	suppressed
Colchicine	Colchicine	20	suppressed
Felodipine Er	Felodipine	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Lurasidone Hcl	Lurasidone Hcl	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	18	suppressed
Linzess	Linaclotide	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Methylprednisolone	Methylprednisolone	17	15
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Estradiol	Estradiol	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Glipizide Er	Glipizide	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Temazepam	Temazepam	13	suppressed
Torsemide	Torsemide	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Donepezil Hcl	Donepezil Hcl	11	suppressed
Eplerenone	Eplerenone	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nexletol	Bempedoic Acid	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error